The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Jazz Pharmaceuticals
Research Funding - InhibRx; Janssen
Patents, Royalties, Other Intellectual Property - AI Therapeutics
SARC037: Results of phase I study of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in relapsed/refractory Ewing sarcoma (ES).
 
Patrick Grohar
No Relationships to Disclose
 
Karla V. Ballman
Consulting or Advisory Role - Agenus; Takeda
Patents, Royalties, Other Intellectual Property - Prostate cancer signature patent (Inst)
Expert Testimony - Janssen Oncology; Mylan; Sanofi
 
Rachel Heise
Employment - CSL Behring (I)
Stock and Other Ownership Interests - CSL Behring (I)
 
John Glod
Research Funding - AdaptImmune; GlaxoSmithKline/Adaptimmune (Inst)
 
Mary Frances Wedekind
No Relationships to Disclose
 
Leo Mascarenhas
Consulting or Advisory Role - Amgen; Bayer (Inst)
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); E.R. Squibb Sons, LLC (Inst); Incyte (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Children's Oncology Group Foundation; The Pablove Foundation
 
Jenna Marie Gedminas
No Relationships to Disclose
 
Steven G. DuBois
Consulting or Advisory Role - Amgen; Bayer; Jazz Pharmaceuticals
Research Funding - Bayer (Inst); BMS (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Robert G. Maki
Employment - PEEL Therapeutics
Consulting or Advisory Role - Bayer; Deciphera; Ipsen; PEEL Therapeutics; UpToDate
Speakers' Bureau - MJH Life Sciences
Research Funding - Amgen (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); C4 Therapeutics (Inst); Daiichi (Inst); Exelixis (Inst); InhibRx (Inst); PEEL Therapeutics (Inst); Presage Biosciences (Inst); Rain Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); SARC: Sarcoma Alliance for Research though Collaboration (Inst); SpringWorks Therapeutics (Inst); SynOx (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
 
Brian D. Crompton
Employment - Acceleron Pharma (I); Generate Biomedicines (I)
Stock and Other Ownership Interests - Acceleron Pharma (I)
Consulting or Advisory Role - Animal Cancer Foundation; AstraZeneca; PetDx
Research Funding - Gradalis
 
Masanori Hayashi
No Relationships to Disclose
 
Cody J. Peer
No Relationships to Disclose
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); Propella Therapeutics (Inst); TRACON Pharma (Inst)
 
Maria Liza Lindenberg
No Relationships to Disclose
 
Esther Mena Gonzalez
No Relationships to Disclose
 
Rochelle Bagatell
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
Theodore Willis Laetsch
Stock and Other Ownership Interests - Advanced Microbubbles
Consulting or Advisory Role - AI Therapeutics; Aptitude Health; Bayer; GentiBio; Jazz Pharmaceuticals; Jumo Health; Massive Bio; Medscape; Menarini; Novartis; Pyramid Biosciences; Targeted Oncology; Treeline Biosciences
Research Funding - Advanced Accelerator Applications/Novartis; Bayer (Inst); BioAtla; Bristol-Myers Squibb; Lilly; Pfizer (Inst); Roche; Roche/Genentech; Taiho Oncology; Turning Point Therapeutics (Inst)
 
Brigitte C. Widemann
No Relationships to Disclose
 
Denise K. Reinke
No Relationships to Disclose
 
Rashmi Chugh
Consulting or Advisory Role - Deciphera; Epizyme; Jazz Pharmaceuticals
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Cogent Biosciences (Inst); Cornerstone Pharmaceuticals (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Janssen (Inst); Mundipharma (Inst); Pfizer (Inst); Plexxikon (Inst); PTC Therapeutics (Inst); Qilu Puget Sound Biotherapeutics (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer
Expert Testimony - Meyers Law (Inst)